Management of Hypertriglyceridemia: Common Questions and Answers - American Family ...
Sep 15, 2020 - Hypertriglyceridemia, defined as fasting serum triglyceride levels of 150 mg per dL or higher, is associated with increased risk of cardiovascular disease. Severely elevated triglyceride levels (500 mg per dL or higher) increase the risk of pancreatitis. Common risk factors for ...
American Family Physician : Article
https://www.aafp.org/afp/2020/0915/p347.html
Hyperlipidemia - American Family Physician
Jan 15, 2021 - This collection features AFP content on hyperlipidemia and related issues, including dyslipidemia, hypercholesterolemia, hypertriglyceridemia, kidney disease, lipid disorders, metabolic syndrome, statins, and triglyceride levels. This collection features AFP content on hyperlipidemia ...
- Screening and Diagnosis
- Prevention
- Treatment
- Editorials and Letters
- Improving Practice
- Patient Education, Self-Care
- Other AFP Content
American Family Physician : AFP By Topic
https://www.aafp.org/afp/topicModules/viewTopicModule.htm?topicModuleId=13
Small Reduction in Cardiovascular Outcome After Ischemic Stroke with Lower LDL Target, ...
Aug 15, 2020 - A lower LDL target slightly reduced the likelihood of a broad composite outcome (number needed to treat [NNT] = 43 over 3.5 years), largely by reducing nonfatal strokes (NNT = 77; statistical significance not reported).
American Family Physician : POEMs
https://www.aafp.org/afp/2020/0815/p247.html
Icosapent Ethyl (Vascepa) for Hyperlipidemia/Hypercholesterolemia to Reduce Risk of ...
Jan 15, 2021 - Icosapent ethyl is safe, well tolerated and effective in preventing ischemic events including stroke and heart attack.
American Family Physician : STEPS
https://www.aafp.org/afp/2021/0115/p117.html
Omega-3 Fatty Acids and Cardiovascular Disease - Implementing AHRQ Effective Health ...
May 1, 2018 - What is the effect of omega-3 fatty acid supplementation on cardiovascular outcomes?
American Family Physician : Implementing AHRQ Effective Health Care Reviews
https://www.aafp.org/afp/2018/0501/p562.html
Statins Ineffective for Primary Prevention of Cardiovascular Disease in Patients 75 ...
Apr 1, 2019 - In this retrospective study, statin treatment in patients 75 years or older without preexisting CVD did not change the likelihood of developing CVD or reduce any-cause mortality. However, patients 75 to 84 years of age with diabetes mellitus benefitted from treatment. These results ...
American Family Physician : POEMs
https://www.aafp.org/afp/2019/0401/p461.html
navigate_before 1 navigate_next